California Life Sciences Association (CLSA), the trade association representing Californias innovative life sciences sector, today applauded the U.S. House passage of H.R. 6378, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018, legislation which is critical for safeguarding our nations biodefense and pandemic preparedness enterprise. The bill now awaits U.S. Senate action. The following statement can be attributed to Sara Radcliffe, President & CEO, CLSA:
California Life Sciences Association (CLSA) applauds yesterdays U.S. House passage of H.R. 6378, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018, legislation that will strengthen and improve our national preparedness and response for public health emergencies and accelerate medical countermeasure R&D. The recent Ebola and Zika outbreaks and ongoing threats from terrorist organizations like ISIS have repeatedly exposed our nations continued vulnerability to bioterror and pandemic threats, demonstrating the need for robust biodefense preparedness.
CLSA commends the leadership of Reps. Anna G. Eshoo (D-Palo Alto) and Susan W. Brooks (R-Ind.) for their careful and dedicated work on this important issue. On behalf of Californias life sciences innovators, a sector with over 3,000 firms employing 300,000 people, we urge the U.S. Senates swift action on this critical legislation, which will bolster our nations biodefense preparedness and response capabilities.
Click here to view CLSAs support letter and learn more about the bill.
- Learn more about the California life sciences industry
- View CLSAs Legislative Action Center
- Watch CLSAs Faces of California Biomedical Innovation Web Series
- View CLSAs Advocacy Priorities
- View upcoming CLSA events
About California Life Sciences Association (CLSA)
WANT TO BUILD A FINANCIAL EMPIRE?
Subscribe to the Global Banking & Finance Review Newsletter for FREE Get Access to Exclusive Reports to Save Time & Money
By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
California Life Sciences Association (CLSA) is the states largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow Californias life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged. Visit CLSA at www.califesciences.org, and follow us on Twitter @CALifeSciences, Facebook, Instagram, LinkedIn and YouTube.